{"id":7289,"date":"2025-05-29T15:22:15","date_gmt":"2025-05-29T15:22:15","guid":{"rendered":"https:\/\/www.nfp-drugs.bg\/en\/?p=7289"},"modified":"2025-07-01T14:42:06","modified_gmt":"2025-07-01T14:42:06","slug":"lifetime-prevalence-of-drug-use-among-the-general-population-adults-aged-15-64-in-bulgaria","status":"publish","type":"post","link":"https:\/\/www.nfp-drugs.bg\/en\/lifetime-prevalence-of-drug-use-among-the-general-population-adults-aged-15-64-in-bulgaria\/","title":{"rendered":"Lifetime prevalence of drug use among the general population (adults aged 15-64) in Bulgaria"},"content":{"rendered":"\n
\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n
Prevalence of psychoactive substance use
Prevalence of medication use
Prevalence of drug use<\/a>
Drug prevention
Treatment supply<\/a>
Treatment demand
Health consequences<\/a>
Harm reduction<\/a>
Drug-related crimes<\/a>
Drug market<\/a>
Drug use and prison<\/a>
Monitoring of publications<\/a>
Attitudes to legal framework changes<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Source: National population adult survey on attitudes and use of psychoactive substances among the general population (aged 15-64). The survey was conducted in the period October-November 2024 on behalf of and with the methodological support of the National Focal Point on Drugs and Drug Addictions by Sova 5 Agency, covering 4002 individuals across the country, and using the “face-to-face” method with a tablet. <\/p>\n<\/div>\n\n\n\n

\n

Lifetime prevalence of drug use among the general population (adults aged 15-64) (by sex, 2024)<\/strong><\/p>\n\n\n\n

Type of drugs<\/strong><\/td>Males<\/strong><\/td>Females<\/strong><\/td>Total<\/strong><\/td>Interval (from)<\/strong><\/td>Interval (to)<\/strong><\/td>Interval (from, number)<\/strong><\/td>Interval (to, number)<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>17.9%<\/strong><\/td>7.7%<\/strong><\/td>12.9%<\/strong><\/td>11.9%<\/strong><\/td>13.9%<\/strong><\/td>473 000<\/strong><\/td>556 000<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/td>16.9%<\/strong><\/td>7.1%<\/strong><\/td>12.1%<\/strong><\/td>11.1%<\/strong><\/td>13.1%<\/strong><\/td>441 000<\/strong><\/td>522 000<\/strong><\/td><\/tr>
Herbal cannabis<\/td>16.6%<\/td>7.1%<\/td>11.9%<\/strong><\/td>10.9%<\/td>12.9%<\/td>435 000<\/td>515 000<\/td><\/tr>
Cannabis resin<\/td>5.6%<\/td>1.8%<\/td>3.7%<\/strong><\/td>3.1%<\/td>4.3%<\/td>124 000<\/td>171 000<\/td><\/tr>
Opioids (total)<\/strong><\/td>4.1%<\/strong><\/td>1.6%<\/strong><\/td>2.9%<\/strong><\/td>2.4%<\/strong><\/td>3.4%<\/strong><\/td>95 000<\/strong><\/td>136 000<\/strong><\/td><\/tr>
Heroin<\/td>3.1%<\/td>1.2%<\/td>2.2%<\/strong><\/td>1.7%<\/td>2.6%<\/td>69 000<\/td>105 000<\/td><\/tr>
Methadone<\/td>0.7%<\/td>0.1%<\/td>0.4%<\/strong><\/td>0.2%<\/td>0.6%<\/td>8 900<\/td>25 000<\/td><\/tr>
Other opioids (morphine, codeine)<\/td>1.4%<\/td>0.5%<\/td>0.9%<\/strong><\/td>0.6%<\/td>1.2%<\/td>26 000<\/td>50 000<\/td><\/tr>
Stimulants (total)<\/strong><\/td>10.0%<\/strong><\/td>5.2%<\/strong><\/td>7.6%<\/strong><\/td>6.8%<\/strong><\/td>8.4%<\/strong><\/td>272 000<\/strong><\/td>338 000<\/strong><\/td><\/tr>
Cocaine<\/td>2,5%<\/td>1,0%<\/td>1,7%<\/strong><\/td>1,3%<\/td>2,1%<\/td>53 000<\/td>85 000<\/td><\/tr>
Amphetamine<\/td>7,8%<\/td>3,7%<\/td>5,7%<\/strong><\/td>5,0%<\/td>6,5%<\/td>201 000<\/td>258 000<\/td><\/tr>
Methamphetamine<\/td>4,2%<\/td>1,5%<\/td>2,9%<\/strong><\/td>2,4%<\/td>3,4%<\/td>94 000<\/td>135 000<\/td><\/tr>
Ecstasy<\/td>5,1%<\/td>2,8%<\/td>4,0%<\/strong><\/td>3,4%<\/td>4,6%<\/td>135 000<\/td>184 000<\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>2,1%<\/strong><\/td>1,1%<\/strong><\/td>1,6%<\/strong><\/td>1,2%<\/strong><\/td>2,0%<\/strong><\/td>48 000<\/strong><\/td>79 000<\/strong><\/td><\/tr>
LSD<\/td>1,5%<\/td>0,7%<\/td>1,1%<\/strong><\/td>0,8%<\/td>1,4%<\/td>31 000<\/td>57 000<\/td><\/tr>
Hallucinogenic mushrooms<\/td>1.6%<\/td>0.7%<\/td>1.1%<\/strong><\/td>0.8%<\/td>1.5%<\/td>33 000<\/td>59 000<\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>2.1%<\/strong><\/td>0.8%<\/strong><\/td>1.4%<\/strong><\/td>1.1%<\/strong><\/td>1.8%<\/strong><\/td>42 000<\/strong><\/td>71 500<\/strong><\/td><\/tr>
Inhalants<\/strong><\/td>0.6%<\/strong><\/td>0.0%<\/strong><\/td>0.3%<\/strong><\/td>0.1%<\/strong><\/td>0.5%<\/strong><\/td>5 000<\/strong><\/td>19 000<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>1.9%<\/strong><\/td>0.6%<\/strong><\/td>1.2%<\/strong><\/td>0.9%<\/strong><\/td>1.6%<\/strong><\/td>36 000<\/strong><\/td>64 000<\/strong><\/td><\/tr><\/tbody><\/table>
Note: The confidence interval is calculated on a 95% confidence level.<\/sub><\/figcaption><\/figure>\n\n\n\n

Lifetime prevalence of drug use among the general population (adults aged 15-64) (by settlement, 2024)<\/strong><\/p>\n\n\n\n

Type of drugs<\/strong><\/td>Sofia (capital)<\/strong><\/td>District <\/strong>city<\/strong><\/td>Non-district city<\/strong><\/td>Village<\/strong><\/td>Total<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>16.9%<\/strong><\/td>15.7%<\/strong><\/td>13.8%<\/strong><\/td>5.0%<\/strong><\/td>12.9%<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/td>16.9%<\/strong><\/td>13.4%<\/strong><\/td>13.5%<\/strong><\/td>4.7%<\/strong><\/td>12.1%<\/strong><\/td><\/tr>
Herbal cannabis<\/td>16.6%<\/td>13.2%<\/td>13.4%<\/td>4.6%<\/td>11.9%<\/strong><\/td><\/tr>
Cannabis resin<\/td>6.1%<\/td>3.8%<\/td>4.0%<\/td>1.1%<\/td>3.7%<\/strong><\/td><\/tr>
Opioids (total)<\/strong><\/td>4.5%<\/strong><\/td>3.7%<\/strong><\/td>2.8%<\/strong><\/td>0.6%<\/strong><\/td>2.9%<\/strong><\/td><\/tr>
Heroin<\/td>3.3%<\/td>2.6%<\/td>2.3%<\/td>0.5%<\/td>2.2%<\/strong><\/td><\/tr>
Methadone<\/td>0.7%<\/td>0.7%<\/td>0.1%<\/td>0.2%<\/td>0.4%<\/strong><\/td><\/tr>
Other opioids (morphine, codeine) <\/td>1.4%<\/td>1.3%<\/td>0.9%<\/td>0.2%<\/td>0.9%<\/strong><\/td><\/tr>
Stimulants (total)<\/strong><\/td>11.2%<\/strong><\/td>10.9%<\/strong><\/td>6.4%<\/strong><\/td>2.0%<\/strong><\/td>7.6%<\/strong><\/td><\/tr>
Cocaine<\/td>2.2%<\/td>2.8%<\/td>1.4%<\/td>0.4%<\/td>1.7%<\/strong><\/td><\/tr>
Amphetamine<\/td>8.2%<\/td>7.7%<\/td>5.2%<\/td>1.9%<\/td>5.7%<\/strong><\/td><\/tr>
Methamphetamine<\/td>4.7%<\/td>3.6%<\/td>2.6%<\/td>0.6%<\/td>2.9%<\/strong><\/td><\/tr>
Ecstasy<\/td>6.0%<\/td>5.4%<\/td>3.7%<\/td>0.9%<\/td>4.0%<\/strong><\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>2.5%<\/strong><\/td>2.1%<\/strong><\/td>1.3%<\/strong><\/td>0.6%<\/strong><\/td>1.6%<\/strong><\/td><\/tr>
LSD<\/td>1.8%<\/td>1.6%<\/td>0.8%<\/td>0.3%<\/td>1.1%<\/strong><\/td><\/tr>
Hallucinogenic mushrooms<\/td>1.8%<\/td>1.5%<\/td>0.9%<\/td>0.5%<\/td>1.1%<\/strong><\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>2.4%<\/strong><\/td>2.0%<\/strong><\/td>1.0%<\/strong><\/td>0.4%<\/strong><\/td>1.4%<\/strong><\/td><\/tr>
Inhalants<\/strong><\/td>0.6%<\/strong><\/td>0.3%<\/strong><\/td>0.2%<\/strong><\/td>0.1%<\/strong><\/td>0.3%<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>1.3%<\/strong><\/td>1.9%<\/strong><\/td>1.3%<\/strong><\/td>0.4%<\/strong><\/td>1.2%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n\n\n\n

Lifetime prevalence of drug use among the general population (adults aged 15-64) (by age groups, 2024)<\/strong><\/p>\n\n\n\n

Type of drugs<\/strong><\/td>15-24 (males)<\/strong><\/td>15-24 (females)<\/strong><\/td>15-24 (total)<\/strong><\/td>25-34 (males)<\/strong><\/td>25-34 (females)<\/strong><\/td>25-34 (total)<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>21.0%<\/strong><\/td>11.9%<\/strong><\/td>16.5%<\/strong><\/td>17.0%<\/strong><\/td>10.5%<\/strong><\/td>13.7%<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/strong><\/td>20.1%<\/strong><\/td>10.6%<\/strong><\/td>15.4%<\/strong><\/td>16.3%<\/strong><\/td>9.9%<\/strong><\/td>13.0%<\/strong><\/td><\/tr>
Herbal cannabis<\/td>19.7%<\/td>10.6%<\/td>15.2%<\/strong><\/td>16.3%<\/td>9.6%<\/td>12.9%<\/strong><\/td><\/tr>
Cannabis resin<\/td>6.7%<\/td>1.5%<\/td>4.2%<\/strong><\/td>5.1%<\/td>2.4%<\/td>3.7%<\/strong><\/td><\/tr>
Opioids (total)<\/strong><\/strong><\/td>5.4%<\/strong><\/td>1.9%<\/strong><\/td>3.7%<\/strong><\/td>2.6%<\/strong><\/td>2.1%<\/strong><\/td>2.3%<\/strong><\/td><\/tr>
Heroin<\/td>3.8%<\/td>1.0%<\/td>2.4%<\/strong><\/td>1.3%<\/td>1.5%<\/td>1.4%<\/strong><\/td><\/tr>
Other opioids (methadone, morphine, codeine)<\/td>1.9%<\/td>1.0%<\/td>1.4%<\/strong><\/td>1.9%<\/td>0.9%<\/td>1.4%<\/strong><\/td><\/tr>
Stimulants (total)<\/strong><\/td>13.7%<\/strong><\/td>7.7%<\/strong><\/td>10.7%<\/strong><\/td>11.5%<\/strong><\/td>8.7%<\/strong><\/td>10.1%<\/strong><\/td><\/tr>
Cocaine<\/td>3.8%<\/td>1.6%<\/td>2.7%<\/strong><\/td>3.8%<\/td>1.8%<\/td>2.8%<\/strong><\/td><\/tr>
Amphetamine<\/td>11.1%<\/td>4.8%<\/td>8.0%<\/strong><\/td>8.0%<\/td>4.8%<\/td>6.4%<\/strong><\/td><\/tr>
Methamphetamine<\/td>4.1%<\/td>1.6%<\/td>2.9%<\/strong><\/td>5.8%<\/td>2.1%<\/td>3.9%<\/strong><\/td><\/tr>
Ecstasy<\/td>6.4%<\/td>4.2%<\/td>5.3%<\/strong><\/td>6.4%<\/td>6.0%<\/td>6.2%<\/strong><\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>3.2%<\/strong><\/td>0.6%<\/strong><\/td>1.9%<\/strong><\/td>3.5%<\/strong><\/td>1.5%<\/strong><\/td>2.5%<\/strong><\/td><\/tr>
LSD<\/td>1.9%<\/td>0.6%<\/td>1.3%<\/strong><\/td>1.6%<\/td>1.2%<\/td>1.4%<\/strong><\/td><\/tr>
Hallucinogenic mushrooms<\/td>2.9%<\/td>0.3%<\/td>1.6%<\/strong><\/td>3.2%<\/td>0.6%<\/td>1.9%<\/strong><\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>2.9%<\/strong><\/td>1.6%<\/strong><\/td>2.2%<\/strong><\/td>1.3%<\/strong><\/td>0.6%<\/strong><\/td>0.9%<\/strong><\/td><\/tr>
Inhalants<\/strong><\/strong><\/td>0.6%<\/strong><\/td>0.0%<\/strong><\/td>0.3%<\/strong><\/td>0.6%<\/strong><\/td>0.0%<\/strong><\/td>0.3%<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>2.2%<\/strong><\/td>1.0%<\/strong><\/td>1.6%<\/strong><\/td>1.6%<\/strong><\/td>0.3%<\/strong><\/td>0.9%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
Type of drugs<\/strong><\/td>35-44 (males)<\/strong><\/td>35-44 (females)<\/strong><\/td>35-44 (total)<\/strong><\/td>45-54 (males)<\/strong><\/td>45-54 (females)<\/strong><\/td>45-54 (total)<\/strong><\/td>55-64 (males)<\/strong><\/td>55-64 (females)<\/strong><\/td>55-64 (total)<\/strong><\/td><\/tr>
Any illegal drugs<\/strong><\/td>19.8%<\/strong><\/td>10.5%<\/strong><\/td>15.0%<\/strong><\/td>22.8%<\/strong><\/td>6.8%<\/strong><\/td>15.1%<\/strong><\/td>9.9%<\/strong><\/td>0.5%<\/strong><\/td>5.5%<\/strong><\/td><\/tr>
Cannabis (total)<\/strong><\/strong><\/td>18.4%<\/strong><\/td>9.5%<\/strong><\/td>13.7%<\/strong><\/td>21.8%<\/strong><\/td>6.5%<\/strong><\/td>14.5%<\/strong><\/td>8.9%<\/strong><\/td>0.5%<\/strong><\/td>5.0%<\/strong><\/td><\/tr>
Herbal cannabis<\/td>17.9%<\/td>9.5%<\/td>13.5%<\/strong><\/td>21.4%<\/td>6.5%<\/td>14.3%<\/strong><\/td>8.7%<\/td>0.5%<\/td>4.9%<\/strong><\/td><\/tr>
Cannabis resin<\/td>6.7%<\/td>3.1%<\/td>4.8%<\/strong><\/td>7.3%<\/td>1.7%<\/td>4.6%<\/strong><\/td>2.5%<\/td>0.0%<\/td>1.3%<\/strong><\/td><\/tr>
Opioids (total)<\/strong><\/strong><\/td>6.9%<\/strong><\/td>2.4%<\/strong><\/td>4.6%<\/strong><\/td>4.6%<\/strong><\/td>1.7%<\/strong><\/td>3.2%<\/strong><\/td>1.4%<\/strong><\/td>0.0%<\/strong><\/td>0.8%<\/strong><\/td><\/tr>
Heroin<\/td>5.5%<\/td>1.8%<\/td>3.5%<\/strong><\/td>3.8%<\/td>1.7%<\/td>2.8%<\/strong><\/td>1.0%<\/td>0.0%<\/td>0.6%<\/strong><\/td><\/tr>
Other opioids (methadone, morphine, codeine)<\/td>2.4%<\/td>1.1%<\/td>1.7%<\/strong><\/td>1.4%<\/td>0.0%<\/td>0.7%<\/strong><\/td>0.6%<\/td>0.0%<\/td>0.3%<\/strong><\/td><\/tr>
Stimulants (total)<\/strong><\/strong><\/td>14.6%<\/strong><\/td>7.5%<\/strong><\/td>10.9%<\/strong><\/td>10.3%<\/strong><\/td>3.5%<\/strong><\/td>7.0%<\/strong><\/td>2.5%<\/strong><\/td>0.0%<\/strong><\/td>1.3%<\/strong><\/td><\/tr>
Cocaine<\/td>3.1%<\/td>1.8%<\/td>2.4%<\/strong><\/td>2.2%<\/td>0.0%<\/td>1.2%<\/strong><\/td>0.4%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Amphetamine<\/td>11.2%<\/td>6.2%<\/td>8.6%<\/strong><\/td>8.1%<\/td>3.1%<\/td>5.7%<\/strong><\/td>2.1%<\/td>0.0%<\/td>1.1%<\/strong><\/td><\/tr>
Methamphetamine<\/td>6.9%<\/td>2.9%<\/td>4.8%<\/strong><\/td>4.4%<\/td>1.1%<\/td>2.8%<\/strong><\/td>0.6%<\/td>0.0%<\/td>0.3%<\/strong><\/td><\/tr>
Ecstasy<\/td>6.9%<\/td>3.7%<\/td>5.3%<\/strong><\/td>5.5%<\/td>1.3%<\/td>3.5%<\/strong><\/td>1.6%<\/td>0.0%<\/td>0.9%<\/strong><\/td><\/tr>
Hallucinogens (total)<\/strong><\/td>3.3%<\/strong><\/td>2.2%<\/strong><\/td>2.7%<\/strong><\/td>1.2%<\/strong><\/td>0.9%<\/strong><\/td>1.0%<\/strong><\/td>0.4%<\/strong><\/td>0.0%<\/strong><\/td>0.2%<\/strong><\/td><\/tr>
LSD<\/td>2.9%<\/td>1.3%<\/td>2.1%<\/strong><\/td>1.0%<\/td>0.4%<\/td>0.7%<\/strong><\/td>0.4%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Hallucinogenic mushrooms<\/td>1.9%<\/td>1.8%<\/td>1.8%<\/strong><\/td>0.8%<\/td>0.4%<\/td>0.6%<\/strong><\/td>0.4%<\/td>0.0%<\/td>0.2%<\/strong><\/td><\/tr>
Synthetic cannabinoids<\/strong><\/td>2.9%<\/strong><\/td>0.9%<\/strong><\/td>1.8%<\/strong><\/td>2.4%<\/strong><\/td>0.9%<\/strong><\/td>1.7%<\/strong><\/td>1.0%<\/strong><\/td>0.0%<\/strong><\/td>0.6%<\/strong><\/td><\/tr>
Inhalants<\/strong><\/td>0.5%<\/strong><\/td>0.0%<\/strong><\/td>0.2%<\/strong><\/td>0.8%<\/strong><\/td>0.0%<\/strong><\/td>0.4%<\/strong><\/td>0.4%<\/strong><\/td>0.0%<\/strong><\/td>0.2%<\/strong><\/td><\/tr>
Combination of two or more substances<\/strong><\/td>1.9%<\/strong><\/td>1.1%<\/strong><\/td>1.5%<\/strong><\/td>2.6%<\/strong><\/td>0.7%<\/strong><\/td>1.7%<\/strong><\/td>1.0%<\/strong><\/td>0.0%<\/strong><\/td>0.6%<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"

Prevalence of psychoactive substance usePrevalence of medication usePrevalence of drug useDrug preventionTreatment supplyTreatment demandHealth consequencesHarm reductionDrug-related crimesDrug marketDrug use and prisonMonitoring of publicationsAttitudes to legal framework changes Source: National population adult survey on attitudes and use of psychoactive substances among the general population (aged 15-64). The survey was conducted in the period October-November 2024 on […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[84,86],"tags":[],"_links":{"self":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7289"}],"collection":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/comments?post=7289"}],"version-history":[{"count":4,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7289\/revisions"}],"predecessor-version":[{"id":7477,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/posts\/7289\/revisions\/7477"}],"wp:attachment":[{"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/media?parent=7289"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/categories?post=7289"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nfp-drugs.bg\/en\/wp-json\/wp\/v2\/tags?post=7289"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}